Table 2 Outcomes of the included studies
From: A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes
Ref. | mDFS | Local recurrence (LSS/amputation) | 5-year survival (LSS/amputation) | Metastatic occurrence (LSS/amputation) | Follow-up (range) |
|---|---|---|---|---|---|
Ferrari et al. | 14 (2–96) | (16/7) | (36/23) | (40/23) | 130 (114–153) |
Bacci et al. | 22.9 (10–49) | (2/1) | (18/3) | (6/4) | 96 (60–144) |
Edmonson et al. | 22.2 (9–64) | (0/11) | (0/20) | (1/7) | 60 (31–74) |
Gherlinzoni et al. | 20 (5–88) | (19/13) | (67/56) | (87/67) | 64 (19–88) |
Goorin et al. | 20 (6–67) | (17/10) | (26/29) | (21/24) | 56 (7–120) |
Zhang et al. | 18 (9–62) | (9/6) | (11/10) | (9/7) | 62 (31–71) |
Sha et al. | 23 (11–43) | (5/3) | (17/6) | (12/9) | 55 (8–175) |
Niu et al. | 24 (9–64) | (21/13) | (56/34) | (35/15) | 24 (32–145) |
Bramer et al. | – | (6/2) | (30/8) | – | 54.7 (8–146) |
Ferguson et al. | – | (2/0) | (7/3) | – | – |